Letter by Vos et al Regarding Article, “Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials”
2010 ◽
Vol 121
(9)
◽
pp. 1069-1077
◽
Keyword(s):
2003 ◽
Vol 92
(4)
◽
pp. 17-22
◽
Keyword(s):
2006 ◽
Vol 98
(6)
◽
pp. 746-750
◽
2010 ◽
Vol 106
(2)
◽
pp. 204-209
◽
Keyword(s):
2020 ◽
Vol 9
(3)
◽
2017 ◽
Vol 54
(5)
◽
pp. 661-662